Abstract
Clinical investigations were made on CS-1170, and the following conclusions were obtained.
CS-1170 was injected intravenously at a dose of 0.5 or 1.0 g twice daily for 5 days.
1) As for 3 cases of acute pyelonephritis with underlying disease, the results were effective in 2 cases, and ineffective in 1 case.
2) As to 7 cases of chronic complicated cystitis with underlying disease, effective results were noticed in all cases. That is, bacteria were eradicated in all cases, though the improvement ratio of leucocytes in urine was 30%.
3) As to the side effects, subjective symptoms, blood pictures and blood biochemical values presented no abnormalities which would be attributed to the drug in all 12 cases treated.
